fluoxymesterone has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuzawa, A; Yamamoto, T | 1 |
| Hori, T; Ide, M; Kato, G; Miyake, T; Uchida, N; Yamaguchi, K | 1 |
2 other study(ies) available for fluoxymesterone and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Antitumor effect of two oral steroids, mepitiostane and fluoxymesterone, on a pregnancy-dependent mouse mammary tumor (TPDMT-4).
Topics: Androstanes; Androstanols; Animals; Antineoplastic Agents; Body Weight; Castration; Female; Fluoxymesterone; Male; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Organ Size; Ovary; Pituitary Gland; Pregnancy; Pregnancy, Animal; Sulfides; Transplantation, Isogeneic | 1977 |
2Alpha, 3alpha-epithio-5alpha-androstan-17beta-YL 1-methoxycyclopentyl ether (10364-S), a new orally active anti-estrogenic steroid.
Topics: Adenofibroma; Androstanes; Androstanols; Animals; Castration; Estradiol; Estrogen Antagonists; Ethers; Female; Fluoxymesterone; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Organ Size; Ovary; Rats; Sulfides; Tetrazolium Salts; Uterus; Vagina | 1974 |